Exploring India’s Role as a Global Pharmaceutical Manufacturing Hub

India has long been recognized as the “pharmacy of the world,” and for good reason. With a robust manufacturing base, skilled workforce, and a strong track record in producing high-quality, affordable medicines, India supplies over 20% of the world’s generic drugs. But what’s truly propelling the country forward is its commitment to excellence, innovation, and global healthcare access.

Pharmaceutical companies in India, like Badrivas Biotech, are playing a vital role in this movement. From producing life-saving cardiac and diabetic drugs to advanced nutraceuticals and veterinary solutions, Indian manufacturers are catering to both domestic needs and international markets. Our ability to comply with stringent global regulations—such as WHO-GMP and other regional certifications—makes us reliable partners for brands around the world.

At Badrivas Biotech, we’re proud to contribute to India’s growing presence in global pharma. With over 1500 formulations and decades of experience, we offer white label and third-party manufacturing services to clients across various therapeutic segments. Our state-of-the-art production facilities are equipped with advanced technology and managed by experts who ensure product quality, safety, and regulatory compliance at every stage.

Beyond manufacturing, India’s pharma industry is also known for its affordability and scalability. This enables healthcare companies worldwide to reduce costs while maintaining high standards—something especially critical in today's price-sensitive markets.

As demand for quality medicines continues to rise globally, India is not just keeping pace—it’s leading. At Badrivas Biotech, we’re honored to be a part of this journey, delivering trusted pharmaceutical solutions across borders.